Last updated on September 2017

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer


Brief description of study

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer

Detailed Study Description

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer

For Study Locations, Click Here

Clinical Study Identifier: TX153182

Find a site near you

Start Over

Research Center

Located In: Additional Locations, MN USA
  Connect »